Abstract:As the most prevalent form of birth defect in humans worldwide, congenital heart disease (CHD) is responsible for substantial morbidity and is still the leading cause of birth defect-related demises. Increasing evidence demonstrates that genetic defects play an important role in the pathogenesis of CHD, and mutations in multiple genes, especially in those coding for cardiac core transcription factors, have been causally linked to various CHDs. Nevertheless, CHD is a genetically heterogeneous disease and the genetic determinants underpinning CHD in an overwhelming majority of patients remain elusive. In the current study, genomic DNA was extracted from venous blood samples of 165 unrelated patients with CHD, and the coding exons and splicing junction sites of the HAND1 gene, which encodes a basic helix-loop-helix transcription factor essential for cardiovascular development, were sequenced. As a result, a novel heterozygous mutation, p.R118C, was identified in a patient with tetralogy of Fallot (TOF). The missense mutation, which was absent in 600 referential chromosomes, altered the amino acid that was completely conserved evolutionarily. Biological assays with a dual-luciferase reporter assay system revealed that the R118C-mutant HAND1 protein had significantly reduced transcriptional activity when compared with its wild-type counterpart. Furthermore, the mutation significantly decreased the synergistic activation of a downstream target gene between HAND1 and GATA4, another cardiac core transcription factor associated with TOF. To our knowledge, this is the first report on the association of a HAND1 loss-of-function mutation with enhanced susceptibility to TOF in humans. The findings provide novel insight into the molecular etiology underlying TOF, suggesting potential implications for the improved prophylactic and therapeutic strategies for TOF.

GATA4 loss-of-function mutations underlie familial tetralogy of fallot.

Somatic GATA4 mutation contributes to tetralogy of Fallot

Gata5 Loss-Of-Function Mutations Underlie Tetralogy Of Fallot

Somatic Gata5 Mutations In Sporadic Tetralogy Of Fallot

Somatic Mutations in the GATA6 Gene Underlie Sporadic Tetralogy of Fallot

A Novel GATA6 Mutation in Patients with Tetralogy of Fallot or Atrial Septal Defect

Investigation of somatic NKX2-5, GATA4 and HAND1 mutations in patients with tetralogy of Fallot.

TBX20 Loss-of-function Mutation Responsible for Familial Tetralogy of Fallot or Sporadic Persistent Truncus Arteriosus.

HAND1 Loss-of-Function Mutation Causes Tetralogy of Fallot.

[Novel GATA4 Mutations Identified in Patients with Congenital Atrial Septal Defects].

Whole-exome sequencing revealed novel genetic alterations in patients with tetralogy of Fallot

GATA4 loss-of-function mutations in familial atrial fibrillation.

A Novel Gata4 Mutation Responsible for Congenital Ventricular Septal Defects

A Novel Mutation of GATA4 (K319E) is Responsible for Familial Atrial Septal Defect and Pulmonary Valve Stenosis

Identification of Functional Mutations in GATA4 in Patients with Congenital Heart Disease

DNA Sequencing of TGFβ2 in Sporadic Patients with Tetralogy of Fallot.

[A Novel GATA4 Mutation Leading to Congenital Ventricular Septal Defect].

Identification of novel rare copy number variants associated with sporadic tetralogy of Fallot and clinical implications

Novel GATA6 Mutations Associated with Congenital Ventricular Septal Defect or Tetralogy of Fallot.

GATA4 Loss-of-function Mutation Underlies Familial Dilated Cardiomyopathy.

A Novel HAND2 Loss-of-function Mutation Responsible for Tetralogy of Fallot.